학술논문

Immunohistochemically detected p53 predicts the resistance to cisplatin-based chemotherapy (CT) in locally advanced and advanced non small cell lung cancer (NSCLC).
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; NOV 2001, 7 11, p3741S-p3741S, 1p. Supplement: S
Subject
Language
English
ISSN
10780432